Low incidence of hyperacute graft-versus-host disease (GVHD) with effective GVHD prophylaxis based on anti-thymocyte globulin

Vera Radici^{1

2}, Nicolas Stocker^{1

3}, Rémy Dulery^{1

3}, Eolia Brissot^{1

3}, Anne Bannet^{1

3}, Zoe van de Wyngaert^{1

3}, Simona Sestili^{1

3}, Ramdane Belhocine^{1

3}, Agnes Bonin¹, Tounes Ledraa^{1

3}, Mohamad Mohty^{1

3}, Florent Malard^{1

3}

Affiliations

¹ APHP, Hôpital Saint Antoine, Service d'Hématologie Clinique et de Thérapie cellulaire, Paris, France.
² Clinical Hematology and Bone Marrow Transplant Centre, S. Maria della Misericordia Hospital, University of Udine, Udine, Italy.
³ INSERM, Centre de Recherche Saint-Antoine (CRSA), Sorbonne Université, Paris, France.

Vera Radici et al. Br J Haematol. 2022 Jun.

. 2022 Jun;197(5):630-633.

doi: 10.1111/bjh.18099. Epub 2022 Mar 4.

¹ APHP, Hôpital Saint Antoine, Service d'Hématologie Clinique et de Thérapie cellulaire, Paris, France.
² Clinical Hematology and Bone Marrow Transplant Centre, S. Maria della Misericordia Hospital, University of Udine, Udine, Italy.
³ INSERM, Centre de Recherche Saint-Antoine (CRSA), Sorbonne Université, Paris, France.

No abstract available

References

1. Saliba RM, de Lima M, Giralt S, Andersson B, Khouri IF, Hosing C, et al. Hyperacute GVHD: risk factors, outcomes, and clinical implications. Blood. 2007;109:2751-8.
1. Salyka S, Bipin NS, Didier B, Florent M, Arnon N, Mohamad M. Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission-a review from the acute leukemia working party of the EBMT. Haematologica. 2015;100:859-69.
1. Kanakry CG, Fuchs EJ, Luznik L. Modern approaches to HLA-haploidentical blood or marrow transplantation. Nat Rev Clin Oncol. 2016;13:10-24.
1. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825-8.
1. Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 2015; 21: 389-401.e381.